MINNEAPOLIS, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 24-month ...
MINNEAPOLIS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company focused on transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today ...
MIAMI, July 14, 2023 (GLOBE NEWSWIRE) -- ASPN Annual Conference – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, today announced ...
Relievant Medsystems enrolled the first patient in its clinical study analyzing the Intracept procedure, a minimally invasive approach to treating low back pain. 1. The INTRACEPT study is a Level 1, ...
Persistent lower back pain is a debilitating problem for millions of people around the world, and it’s not something that is easily treated. A technology called Intracept is making waves in this space ...
If you suffer from chronic back pain, you are not alone. Nearly 65 million American adults have suffered from a back pain episode at some point in their lives, and one in four American workers say ...
REDWOOD CITY, Calif., July 21, 2016 /PRNewswire/ -- Relievant Medsystems, Inc., a privately held medical device company pioneering the therapy of nerve ablation within vertebral bodies for the ...
An ongoing clinical trial for a Minnesota company's treatment for lower-back pain is going so well that the company, Relievant Medsystems, has opted to halt new enrollments and offer the treatment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback